Expression of high-risk HPV oncogenes results in a strong overexpression of cellular protein p16 INK4a . Immunohistochemical staining for p16
Cervical cancer is the second leading cause of cancer deaths for women worldwide. 1 Today, cervical cancer screening programs mostly rely on cytology. The Pap-test introduced more than 60 years ago by Papanicolaou 2 remarkably reduced the mortality by cervical cancer. 3 Pap screening has high specificity for disease, but suffers from suboptimal sensitivity and observer subjectivity that is partially compensated by frequent testing. 4 Therefore, supportive molecular alternative methods are highly desirable.
Human papillomavirus is a necessary cause of invasive cervical cancer. 5 Therefore, HPV testing is being discussed as a primary screening method, for triaging of equivocal results, and follow-up after therapeutic intervention. 6 High-risk HPV infections are not sufficient for the development of cervical cancer. Most individuals remain asymptomatic and clear HPV infections spontaneously within approximately 8-10 months. 7 The immortalization of primary human keratinocytes can be sufficiently maintained by the expression of the high-risk HPV E6 and E7 oncogenes. These oncogenes are required for initiation and all subsequent stages of carcinogenic progression. 8 The focus on HPV oncogene mRNA expression could be a promising strategy to identify transformation events, but requires multiplex approaches to deal with HPV type-specific transcripts. The proteins p16
INK4a (CDKN2A) and p14 ARF (CDKN2B) are generally upregulated in transformed cells as a consequence of high-risk HPV E6 and E7 expression. The CDKN2A/B gene locus encodes two proteins, p14 ARF and p16 INK4A , generated by alternative mRNA splicing. 9 The p14 ARF consists of the unique first exon, 1-beta, 15 INK4A promotes the formation of a Rb-E2F repressive transcriptional complex, which also blocks cell cycle progression at the G 1 -S restriction point. 10, 13 The HPV E7 protein binds to the phosphorylated Rb. This event releases the transcription factor E2F, and thereby induces uncontrolled cell replication. A positive feedback control loop leads to overexpression of p16
INK4a in HPV-transformed cells. 14, 15 Cervical cancer was shown to be strongly associated with p16
INK4a and p14 ARF expression by immunohistochemical studies. 11, [16] [17] [18] [19] Immunohistochemical staining for p16
INK4a became the most widely accepted surrogate biomarker in cervical cancer screening. p16
INK4a has the advantage to detect any high-risk HPV infection in conjunction with uncontrolled, malignant cell replication. 20, 21 Furthermore, it has been shown to improve inter-observer agreement on histological diagnosis, 22 and commercial kits are widely used to support histological findings.
Apart from HPV-induced expression, p14 ARF and p16
INK4A also accumulate in many tissues as a function of advancing age as shown in rodents 23 and in human skin. 24 Their physiological function is the control of the state of cellular replicative senescence. Such upregulation in older patients may interfere with the high-risk HPV-related upregulation of p14 ARF and p16 INK4A in cervical intraepithelial neoplasia.
In contrast to the successful establishment of immunohistochemical staining, very little data exists about the use of CDKN2A-derived mRNA in cervical cancer diagnosis. However, despite RNA derived from exfoliated cervical cells being challenging, other mRNA-based biomarkers such as HPV oncogenes, 25 Brn3a, 26 or MCM5, 27 were successfully tested on cervical smears and biopsies.
We analyzed the mRNA expression levels of p16
INK4a and p14 ARF in cervical smears from HPVnegative women with normal cytology and compared it with women with high-grade findings (HSIL). We used validated SYBR-Green I assays in a read-out described by Kanellou et al. 28 Expression was related to b-actin (ACTB) that was used as a housekeeping gene, 29 because it turned out to be the most stable reference in exfoliated cervical cells. 30 The aim of this study was to (i) study p14 ARF 
Patients and methods

Patients
Patient numbers and characteristics are summarized in Table 1 . Pap smears were taken under colposcopic control at the Clinic for Gynecology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Germany. Two smears were taken, the first for cytology and RNA extraction, and the second for HPV typing. To analyze the effect of age, patients with normal results (cytology and HPV test negative) or with high-grade dysplasia were divided into groups of upper and lower mean-age and analyzed for p16
INK4a /p14 ARF mRNA expression. Cytological diagnosis was made by cytopathologists blinded to the real-time PCR results. The study was approved by the IRB (EA4 217-20) and patients consented to the scientific use of scrape material.
HPV Typing
Genomic DNA from cervical smears was extracted with the Genomic DNA Mini Kit (Qiagen, Hilden, Germany) according to the standard protocol and eluted in 160 ml TE buffer. A b-globin PCR was made as described and analyzed on a 2% agarose gel, to monitor DNA quality. 31 The generic GP5 þ /bio6 þ primer set was used to amplify a sequence from the L1 gene of a large number of different HPV types. 31 After PCR amplification, HPV sequences were genotyped by MPG Luminex suspension array technology (Multimetrix, Heidelberg, Germany). 32 
RNA Extraction and cDNA Synthesis
Cervical smears were taken and the cyto-brushes were immediately immersed and stored in RNAlater (Qiagen), and transferred to À201C within 24 h. 
Real-Time PCR
All real-time PCR experiments were performed on a Chromo4 real-time detector (Bio-Rad, Hercules, USA). All quantitative PCRs were prepared in a dedicated facility in a laminar flow benchhood, using aerosol-resistant pipette tips. Specific p16 INK4a and p14 ARF expression was quantitated using a real-time reverse transcriptase PCR assay with SYBR-Green I. The specific primer pairs for p16
INK4a and p14
ARF
, and the temperature were described by Kanellou et al. 28 For normalization, we used ACTB as an internal control. ACTB primers were described by Kreuzer et al. 29 All primer sequences are listed in Table 2 . The temperature protocol was 15 min at 951C, followed by 40 cycles of 30 s at 951C, 1 min at 601C and 30 s at 721C. Melting curves were made between 50 and 951C with a temperature increment of 0.21C. cDNA (1 ml) was amplified in 1 Â Qiagen multiplex mastermix containing 1 Â SYBR-Green I, and 300 nM of each primer.
Each sample was run in duplicate and each run contained two 'no template controls' for each gene.
Expression analysis and statistical evaluation was made using the pair-wise fixed re-allocation randomization test by the Qiagen REST 2009 Software, V2.0.13. 33 Additionally, relative copy numbers were calculated for each patient.
For the purpose of quantification, and to show efficiency and sensitivity, plasmid standard curves were made by cloning the p14 ARF , p16 INK4A , and ACTB amplicons into pCR2.1, using the TOPO TA cloning system (Invitrogen, Groningen, The Netherlands), according to the manufacturer's instructions. Plasmids were verified by sequencing, and serial dilutions of 10 7 -10 2 plasmid copies containing the PCR inserts were made. Standard curves were generated by amplified plasmid DNA serial dilutions.
Results
The efficiency of the real-time PCR assays was tested by evaluating the results of serial template dilutions of plasmid DNA containing the respective amplicons. The efficiency of all assays was high, and all assays had a dynamic range between at least 10 2 -10 7 ( Figure 1a ). Highly specific melting curves are shown for representative samples (Figure 1b) . RNA integrity number (RIN) was analyzed in each of five cervical smears and cervical cell lines (CasKi, HeLa, SiHa and the recently developed HPV16-positive cell lines, Goe and Marq). As expected, RNA isolates from smears were highly degraded (RIN (mean) ¼ 4.6, range ¼ 2.4-6.6). RNA from cervical cancer cell lines showed less degradation (RIN (mean) ¼ 8.5, range ¼ 5.1-9.1), although it was exposed to the same storage and extraction procedure. The cervical cancer cell lines were used as positive controls to estimate the expression level of samples with good RNA quality and 100% transformed cells. The p14 ARF and p16 INK4A expression levels relative to ACTB were significantly upregulated in HSIL patients. A significant age-related bias was observed. The results are summarized in Table 3 . The data show the N-fold upregulation that was calculated in 45 high-risk HPV-positive tested women with HSIL diagnosis compared with 48 normal women with no detectable HPV infection. Both groups were divided at their median age into four subgroups (Table 1) . To analyze the sensitivity and specificity of these tests, we calculated the individual p14 ARF and p16 INK4a copy numbers in relation to ACTB. The respective cut-offs were defined as the median value for normal patients, plus one s.d. For p16 INK4a , we calculated a sensitivity to detect HSIL positive patients of 79% (95% CI ¼ 65-88%) and a specificity of 83% (95% CI ¼ 67-92%). For p14 ARF , we calculated a sensitivity to detect HSILpositive patients of 74% (95% CI ¼ 60-84%) and a INK4a expression was also described to be a biomarker of age in rodents and in human skin. 23, 24 The influence of age in p16-based cervical cancer screening has not been described yet, and may help to improve data interpretation.
We compared normal HPV-negative patients (n ¼ 48) with high-risk HPV-positive patients referred as HSIL (n ¼ 45) with regard to their p14 ARF and p16 INK4a expression. We used published SYBR-Green I assays and related the expression to the housekeeping gene ACTB. As expected, we found that relative p16
INK4a and p14 ARF transcript frequencies increased significantly in samples of patients with HSIL diagnoses. We also found a significant correlation between the patient age and the increased expression of p16 INK4a and p14 ARF that interfered with HPV-induced upregulation.
Overall, p16 INK4a expression was higher than the p14 ARF expression in HSIL patients. In women with equal diagnosis, both transcripts were significantly upregulated in older patients compared with younger patients (see Table 3 ). This age-dependent upregulation can strongly influence the HPV oncogene-related upregulation of p14 ARF and p16 INK4a . For p16 INK4a , the comparison between younger normal women with older HSIL patients would result in an upregulation of 17.12-fold. In turn, older normal women compared with younger HSIL would result in 2.34-fold higher expression only. Therefore, age induces a bias concerning p14 ARF and p16
INK4a
expression.
Patients in the HSIL group were younger compared with the normal group, because of the higher HPV prevalence in young women. Although the age difference of normal women was wider compared with patients with HSIL diagnosis, the age-related upregulation was in the same range.
The quantification of mRNA using real-time PCR has the advantage to be independent from subjective visual sample assessment, as well as being highthroughput compatible. However, the use of mRNA from exfoliated cervical cells is challenging, because cervical scrapes consist of cervical mucus, cellular debris and mRNA is mostly degraded. This critical fact affords small PCR amplicons, good storage solutions and a rapid sample processing. We tested the RNA integrity number in a subset of patients and found mRNA from cervical smears to be highly degraded. Indeed, some samples may be not suitable for mRNA-based analysis. A total of 11 and 15 out of 45 HSIL patients did not reach sufficient p16 INK4a and p14 ARF levels, respectively. This may be due to insufficient RNA quality. To investigate whether degradation occurred in situ or during storage and extraction, we validated our sampling and extraction procedure by simultaneous treatment of cervical cell lines. The high RNA integrity numbers in the cell lines verified our appropriate extraction and storage procedure. We suggest that beside RNA quality, it may be advantageous to extract the relevant material to reduce the ratio of healthy to dysplastic tissue. Our samples were taken under colposcopic control. This may have enhanced the quality of sampling. Tumor cell enrichment through techniques such as laser capture microdissection was not investigated in this study, as the design aimed to analyze the feasibility of CDKN2A/B mRNA analysis in a standard clinical setting. Our results warrant further analysis of mRNA expression of p16
INK4a and p14 ARF from cervical smears.
